Stage II Rectal Cancer

Explore clinical trials studying Stage II Rectal Cancer. Study availability and eligibility vary by location and protocol.

8 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Stage II Rectal Cancer trial results

Recruiting

NCT03051464

Conditions: Colorectal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +13 more
Locations: UT Southwestern Medical Center Dallas, Texas, United States

Le Centre Hospitalier de l'Université de Montreal Montreal, Quebec, Canada

Jewish General Hospital Montreal, Quebec, Canada

Centre hospitalier universitaire de Québec Québec, Quebec, Canada

Not Yet Recruiting

NCT07688135

Conditions: Colorectal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +10 more
Locations: Not specified

Completed

NCT03154190

Conditions: Acute Myeloid Leukemia, Adenocarcinoma, Adnexal Diseases, +146 more
Locations: Virginia K Crosson Cancer Center Fullerton, California, United States

Completed

NCT04164069

Conditions: Advanced Colorectal Carcinoma, Bile Duct Cancer, Bile Duct Diseases, +41 more
Locations: Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

Completed

NCT02129218

Conditions: Colonic Diseases, Colonic Neoplasms, Colorectal Neoplasms, +16 more
Locations: Case Comprehensive Cancer Center Cleveland, Ohio, United States

Metrohealth Medical Center Cleveland, Ohio, United States

Completed

NCT00433576

Conditions: Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, Colonic Diseases, +18 more
Locations: University of Michigan Ann Arbor, Michigan, United States

Completed

NCT00052559

Conditions: Adenocarcinoma of the Rectum, Colorectal Neoplasms, Digestive System Diseases, +11 more
Locations: Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States

Duke University Medical Center Durham, North Carolina, United States

Completed

NCT00006094

Conditions: Adenocarcinoma of the Rectum, Colorectal Neoplasms, Digestive System Diseases, +11 more
Locations: Cancer and Leukemia Group B Chicago, Illinois, United States